Ordinary Adjustment | Solactive Future Pharmaceutical Europe Index | September 2018

In the ordinary rebalance the following composition will be implemented:

ASTRAZENECA PLC
BAYER AG
GRIFOLS SA CLASS A
GLAXOSMITHKLINE PLC
IPSEN SA
H LUNDBECK AS
MERCK KGAA
NOVARTIS AG
NOVO NORDISK AS CLASS B
RECORDATI SPA
ROCHE HOLDING AG
SANOFI SA
SHIRE PLC
UCB SA
VIFOR PHARMA AG